How practices successfully treat patients who are self-sourcing their medications
Prescription access is changing fast. From GLP-1 weight loss drugs and hormone replacement therapies to compounded medications, more patients are choosing to source them outside traditional clinical pathways. Whether they're turning to wellness clinics, telehealth startups, an online pharmacy, MSV prescription shop, or local medicine shop, buying meds online is now just a few clicks away.
While this trend reflects a lack of access, affordability, and patient experience, it also introduces a growing gap for clinicians. When medications aren't documented in a patient's EHR, the risks multiply not only for patients, but also for providers and care teams tasked with delivering safe, coordinated care.
Keep reading to learn how smarter digital workflows can help practices close the loop without alienating their patients in the process.
The rise of patient-sourced prescriptions
Few drug classes illustrate the DIY Rx trend better than GLP-1 receptor agonists such as semaglutide. Originally approved for diabetes management, these medications have surged in popularity for weight loss, fueled by celebrity endorsements, viral content, and aggressive direct-to-consumer marketing. U.S. spending on GLP-1 prescriptions increased more than 500% between 2018 and 2023 alone.1 Some analyses show utilization trends grew by nearly 150% again in 2024.2
As demand has often outpaced access through traditional primary care channels, patients have been pushed toward alternative sources.
Hormone replacement therapy (HRT) is following a similar trajectory. Whether navigating menopause or seeking testosterone therapy, both male and female patients report long wait times, dismissive encounters, or inconsistent guidance in traditional settings. A 2025 Mayo Clinic study highlighted persistent gaps in this area, finding more than 80% of women with menopausal symptoms had not sought medical care, and only about 1 in 4 were receiving any treatment, including hormone therapy.3
Compounded medications, often marketed as “customized" or “bioidentical," add another layer of complexity, especially when formulations vary widely.
In many cases, patients don't see these choices as going around their doctors. They're simply responding to friction in the healthcare system by using what feels like a practical workaround.
Convenience, cost, and control
Several factors may be driving patients to self-source their medications:
- Speed and convenience. Same-week appointments and home delivery beat months-long waitlists.
- Cost transparency. Cash-pay models can feel simpler than navigating insurance coverage and prior authorizations.
- Perceived autonomy. Patients feel empowered managing their weight, aging, or wellness on their own terms.
- Stigma avoidance. Sensitive conditions may feel easier to address outside a traditional exam room.
From the patient's perspective, these decisions can often feel rational—and even responsible.
The hidden risks of undocumented medications
The most immediate risk of patient-sourced prescriptions is incomplete medication lists. If a GLP-1, hormone therapy, or compounded drug isn't documented in the EHR, clinicians may unknowingly prescribe interacting medications, misinterpret lab results, or overlook side effects.
For example:
- GLP-1s can affect gastric emptying, altering absorption of other oral medications.
- Hormone therapies can influence cardiovascular risk, mood, and metabolic markers.
- Compounded drugs may vary in strength or formulation, making effects harder to predict.
Consider this hypothetical scenario: A patient starts taking compounded semaglutide from an online vendor but doesn't report it at their annual visit, where they are prescribed a new antihypertensive. Weeks later, they develop persistent nausea, dehydration, and unstable blood pressure. Without knowledge of the GLP-1 therapy, the clinician may attribute symptoms to the new drug. An urgent visit, labs, and medication changes may follow, but these steps could have been avoided if a complete medication history had been available.
When adverse events occur, clinicians may be left piecing together what happened after the fact. They may struggle to explain results or decision-making when outcomes don't align with documented care.
Liability and quality of care implications
Undocumented medications also create professional risk. Outcomes may appear unexplained, treatment plans may seem ineffective, and quality metrics can be skewed. In value-based care models, this data gap matters.
If a patient's A1C improves or worsens unexpectedly, or if weight changes rapidly, the absence of a complete medication history can lead to incorrect clinical conclusions. Over time, this undermines trust on both sides of the examination table.
Why patients don't always disclose
Many patients don't intentionally hide self-sourced medications. In most cases, they simply assume prescriptions obtained through virtual clinics, specialty vendors, or digital services belong outside their primary care record. They may also worry their choice will be judged or questioned.
In a healthcare environment defined by multiple portals, medication data becomes scattered across systems that don't naturally talk to one another. When that happens, the responsibility for connecting the dots informally shifts to patients, even though they rarely have the tools or context to do it reliably.
This is where connected health technology changes the dynamic. Rather than placing the burden on patients or expecting clinicians to rely on recall alone, integrated workflows can surface external prescription activity, prompt structured disclosure during intake, and reconcile medications automatically. By embedding these capabilities directly into the clinical workflow, platforms like athenahealth can help normalize transparency, close visibility gaps, and create a shared, accurate medication record. It can set the stage for safer, more coordinated care.
Building better disclosure through digital workflows
Traditional intake forms often lag behind patient reality. To address the DIY Rx trend, practices need digital intake workflows that explicitly ask about:
- Telehealth-prescribed medications
- Compounded drugs
- Weight loss or hormone therapies obtained outside the practice
- Supplements and injectables sourced online
The key is to use neutral, nonjudgmental language that signals curiosity, not necessarily the need for correction.
Proactive medication reconciliation
Medication reconciliation shouldn't be a once-a-year checkbox when prescriptions increasingly originate outside the practice. What works best in this environment is continuous, network-aware reconciliation. That's when workflows are supported by interoperability tools that automatically pull medication histories from pharmacy networks, e-prescribing hubs, and patient-reported inputs.
Unlike traditional reconciliation, which relies heavily on patient recall during visits, these processes combine real-time medication history retrieval, structured patient intake prompts, and automated deduplication. This allows clinicians to see therapies initiated through virtual clinics, specialty vendors, or cash-pay online pharmacies alongside in-network prescriptions.
Embedding patient-reported medications directly into the EHR allows them to be reviewed, verified, and reconciled in real time. This is especially critical for high-impact or long-term therapies. The result is a living medication list that reflects how patients actually access care, not just how prescriptions are written.
Education strategies that encourage transparency
Patients are more likely to disclose if they're self-sourcing when clinicians explain why it matters. Framing medication disclosure as a safety issue, rather than a compliance issue, can change the tone.
Patients are more likely to disclose if they're self-sourcing when clinicians explain why it matters. Framing medication disclosure as a safety issue, rather than a compliance issue, can change the tone.
Effective education strategies include:
- Clear explanations of drug interactions and monitoring needs
- Reassurance that disclosure won't automatically end access
- Normalizing language being used, such as: “Many patients are using online services for medications — let's make sure we account for everything you're taking."
When patients feel respected, they feel comfortable to share more. Acknowledging the realities of modern healthcare — cost pressures, access barriers, and time constraints—builds credibility. Patients don't need lectures; but, instead, they need coordination.
Safer, more coordinated care
The goal isn't to stop patients from seeking care elsewhere. It's to ensure that wherever medications originate, clinicians have the full picture. Integrated data supports safer prescribing, clearer outcomes, and stronger patient-provider relationships.
Moving forward: From DIY to medication reconciliation
The DIY Rx trend doesn't look like it's going away any time soon. It's a new feature of modern healthcare, and a signal that patient expectations have changed. And the ultimate result for practitioners is to offer responsible support.
Practices that adapt to this fragmented ecosystem by modernizing intake, prioritizing medication reconciliation, and fostering open dialogue will be better equipped to manage this shift. Continuing to move forward with incomplete information could be a risk in an increasingly complex medication landscape.
By embracing smarter workflows and integrated data, you can help your practice close the loop on patient-sourced medications. Interoperability is one way healthcare organizations can turn a growing challenge into an opportunity for better care, improved outcomes, and higher levels of patient trust.
